Multivariate Analysis in the Pharmaceutical Industry - 1st Edition - ISBN: 9780128110652, 9780128110669

Multivariate Analysis in the Pharmaceutical Industry

1st Edition

Editors: Ana Patricia Ferreira Jose C. Menezes Mike Tobyn
eBook ISBN: 9780128110669
Paperback ISBN: 9780128110652
Imprint: Academic Press
Published Date: 27th April 2018
Page Count: 464
Sales tax will be calculated at check-out Price includes VAT/GST
209.94
146.96
146.96
146.96
167.95
146.96
146.96
167.95
150.00
105.00
105.00
105.00
120.00
105.00
105.00
120.00
115.00
80.50
80.50
80.50
92.00
80.50
80.50
92.00
131.00
91.70
91.70
91.70
104.80
91.70
91.70
104.80
Unavailable
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Description

Multivariate Analysis in the Pharmaceutical Industry provides industry practitioners with guidance on multivariate data methods and their applications over the lifecycle of a pharmaceutical product, from process development, to routine manufacturing, focusing on the challenges specific to each step. It includes an overview of regulatory guidance specific to the use of these methods, along with perspectives on the applications of these methods that allow for testing, monitoring and controlling products and processes. The book seeks to put multivariate analysis into a pharmaceutical context for the benefit of pharmaceutical practitioners, potential practitioners, managers and regulators.

Users will find a resources that addresses an unmet need on how pharmaceutical industry professionals can extract value from data that is routinely collected on products and processes, especially as these techniques become more widely used, and ultimately, expected by regulators.

Key Features

  • Targets pharmaceutical industry practitioners and regulatory staff by addressing industry specific challenges
  • Includes case studies from different pharmaceutical companies and across product lifecycle of to introduce readers to the breadth of applications
  • Contains information on the current regulatory framework which will shape how multivariate analysis (MVA) is used in years to come

Readership

R&D and manufacturing technical staff in the pharmaceutical industry, pharmaceutical managers, academics in pharmaceutical science, postgraduate students in pharmaceutical science, regulators, MVA professionals joining the pharmaceutical industry

Table of Contents

Section I. Background and Methodology
1. The pre-eminence of multivariate data analysis as a statistical data analysis technique in pharmaceutical R&D and manufacturing
2. The philosophy and fundamentals of handling, modeling and interpreting large data sets - the multivariate chemometrics approach
3. Data processing in multivariate analysis of pharmaceutical processes
4. Theory of sampling (TOS) – a necessary and sufficient guarantee for reliable multivariate data analysis in pharmaceutical manufacturing
5. The ‘how’ of multivariate analysis (MVA) in the pharmaceutical industry: A holistic approach
6. Quality by design in practice

Section II. Applications in Pharmaceutical Development and Manufacturing
7. Multivariate analysis supporting pharmaceutical research
8. Multivariate data analysis for enhancing process understanding, monitoring and control – active pharmaceutical ingredient manufacturing case studies
9. Applications of MVDA and PAT for drug product development and manufacturing
10. Applications of multivariate analysis to monitor and predict pharmaceutical materials properties
11. Mining information from developmental data: process understanding, design space identification, and product transfer
12. A systematic approach to process data analytics in pharmaceutical manufacturing: The data analytics triangle and its application to the manufacturing of a monoclonal antibody
13. Model maintenance
14. Lifecycle management of PAT procedures: Applications to batch and continuous processes
15. Applications of MVA for product quality management: Continued process verification and continuous improvement 
16. The role of multivariate statistical process control in the pharma industry
17. Application of multivariate process modelling for monitoring and control applications in continuous pharmaceutical manufacturing

Section III. Guidance Documents and Regulatory Framework
18. Guidance for compendial use – The USP <1039> chapter
19. Multivariate analysis and the pharmaceutical regulatory framework

 

Details

No. of pages:
464
Language:
English
Copyright:
© Academic Press 2018
Published:
Imprint:
Academic Press
eBook ISBN:
9780128110669
Paperback ISBN:
9780128110652

About the Editor

Ana Patricia Ferreira

Ana Patricia Ferreira

Dr. Ferreira has over 10 years of experience in the application of multivariate analysis in the pharmaceutical industry both in R&D and manufacturing, spanning both small and large molecule applications. Her research and publications focus on the use of multivariate analysis for extraction of information from large data sets spanning diverse topics such as near infrared spectroscopy, process analysis and material characterization.

Affiliations and Expertise

Principal Scientist, Department of Drug Product Science and Technology, Bristol-Myers Squibb, Moreton, UK

Jose C. Menezes

Jose C. Menezes

Dr. Menezes has over 20 years of experience in academia and pharma/biopharma industries where he conducted multiple projects. He is a pioneer of the application of PAT and QbD principles to the bioengineering field. He is the co-editor of three books and has published more than 75 papers and several book chapters on MVA, PAT, QbD, data and knowledge management.

Affiliations and Expertise

Associate Professor, University of Lisbon, Faculty of Pharmacy, Program Director, Pharmaceutical Engineering Master’s Program, Technical University of Lisbon, Lisbon, Portugal

Mike  Tobyn

Mike Tobyn

After training as a pharmacist and getting his PhD, Mike Tobyn joined the faculty in the University of Bath, where he studied and worked under Professor John Staniforth. He has worked for, or consulted for, spinout and large pharmaceutical companies, and excipient suppliers. Mike’s fascination with materials has led him to believe that the properties of materials in processes are governed more by their faults than their intrinsic perfect properties, but that these are more difficult to detect than conventional analysis will allow. Mike has over 20 years of experience in academia and the pharmaceutical industry, and has published more than 75 papers in the fields of oral drug delivery, inhalation drug delivery, and MVA.

Affiliations and Expertise

Research Fellow, Department of Drug Product Science and Technology, Bristol-Myers Squibb, Moreton, UK

Ratings and Reviews